Phosphonic acid compounds as inhibitors of serine proteases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8497373
SERIAL NO

13471876

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORTHO-MCNEIL PHARMACEUTICAL INCRARITAN NJ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Almond,, Jr Harold R Maple Glen, US 14 66
Cesco-Cancian, Sergio Bethlehem, US 29 161
de, Garavilla Lawrence Downingtown, US 15 174
Greco, Michael N Lansdale, US 37 147
Hawkins, Michael J Ambler, US 34 228
Humora, Michael J Cranbury, US 13 70
Nilsen, Christopher Norman Branchburg, US 10 69
Patel, Mitul N Newark, US 13 69
Powell, Eugene Pipersville, US 21 110
Qian, Yun Doylestown, US 17 75
Sorgi, Kirk Leonard Buckingham, US 8 57
Walker, Donald Gilmore Pipersville, US 10 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 30, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00